These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1829909)

  • 21. Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. The EORTC Receptor Study Group.
    Romain S; Lainé Bidron C; Martin PM; Magdelenat H
    Eur J Cancer; 1995; 31A(3):411-7. PubMed ID: 7786610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of short-term pre-operative tamoxifen on steroid receptor and Ki-67 expression in primary breast cancer: an immunocytochemical study.
    Bajetta E; Celio L; Di Leo A; Bartoli C; Pilotti S; Leutner M; Bono A; Ferrari L; Buzzoni R; Zilembo N; De Candis D; Moglia D
    Int J Oncol; 1998 Apr; 12(4):853-8. PubMed ID: 9499446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imprint cytology in immunocytochemical analysis of oestrogen and progesterone receptors of breast carcinoma.
    Helin HJ; Isola JJ; Helin MJ; Helle MJ; Krohn KJ
    J Clin Pathol; 1989 Oct; 42(10):1043-5. PubMed ID: 2685049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oestrogen, progesterone, and androgen receptors in ovarian neoplasia: correlation between immunohistochemical and biochemical receptor analyses.
    van Doorn HC; Burger CW; van der Valk P; Bonfrèr HM
    J Clin Pathol; 2000 Mar; 53(3):201-5. PubMed ID: 10823139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of methodology for estrogen and progesterone receptor protein analysis.
    Menendez-Botet CJ; Schwartz MK
    J Int Fed Clin Chem; 1992 Jul; 4(3):94-100. PubMed ID: 10148301
    [No Abstract]   [Full Text] [Related]  

  • 26. The use of fine-needle aspirates of breast cancers to evaluate hormone-receptor status.
    Lundy J; Lozowski M; Sadri D; Mishriki Y
    Arch Surg; 1990 Feb; 125(2):174-6. PubMed ID: 2302058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the presence of progesterone receptors on the relationship between enzyme immunoassay and steroid-binding assay for oestrogen receptors.
    Marsigliante S; Puddefoot J; Vinson GP; Gilmore OJ
    Biochem Soc Trans; 1990 Aug; 18(4):565-6. PubMed ID: 2276439
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunocytochemical determination of estrogen receptor, progesterone receptor, and 1,25-dihydroxyvitamin D3 receptor in breast cancer and relationship to prognosis.
    Berger U; McClelland RA; Wilson P; Greene GL; Haussler MR; Pike JW; Colston K; Easton D; Coombes RC
    Cancer Res; 1991 Jan; 51(1):239-44. PubMed ID: 1846309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytologic diagnosis of estrogen and progesterone receptors in breast imprints.
    Sasaki M; Morimoto K; Koh M; Wakasa K; Haba T; Kinoshita H
    Acta Cytol; 2002; 46(6):1056-60. PubMed ID: 12462082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors.
    Stierer M; Rosen H; Weber R; Hanak H; Spona J; Tüchler H
    Ann Surg; 1993 Jul; 218(1):13-21. PubMed ID: 8328824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies.
    Elashry-Stowers D; Zava DT; Speers WC; Edwards DP
    Cancer Res; 1988 Nov; 48(22):6462-74. PubMed ID: 3180062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
    Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
    Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The stability of estrogen and progesterone receptor expression on breast carcinoma cells stored as PreservCyt suspensions and as ThinPrep slides.
    Tabbara SO; Sidawy MK; Frost AR; Brosky KR; Coles V; Hecht S; Radcliffe G; Sherman ME
    Cancer; 1998 Dec; 84(6):355-60. PubMed ID: 9915137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of new monoclonal antibodies in detection of estrogen receptor, progesterone receptor, and Her2 protein expression in breast carcinoma cell block sections using conventional microscopy and quantitative image analysis.
    Hanley KZ; Siddiqui MT; Lawson D; Cohen C; Nassar A
    Diagn Cytopathol; 2009 Apr; 37(4):251-7. PubMed ID: 19217031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of nuclear DNA content and hormone receptors in breast cancer by the CAS 100 cell analysis system as related to morphologic grade and biochemical results.
    Rondez R; Yoshizaki C; Pirozynski W
    Anal Quant Cytol Histol; 1991 Aug; 13(4):233-45. PubMed ID: 1930542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steroid receptor measurement in breast cancers: comparison between ligand binding and enzyme-immunoassay in cytosolic and nuclear extracts.
    Luqmani YA; Temmim L; Memon A; Ali MA; Parkar AH
    Int J Cancer; 1997 May; 71(4):526-38. PubMed ID: 9178804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study on breast carcinoma Her2/neu and hormonal receptors status assessed by automated images analysis systems: ACIS III (Dako) and ScanScope (Aperio).
    Słodkowska J; Filas V; Buszkiewicz E; Trzeciak P; Wojciechowski M; Koktysz R; Staniszewski W; Breborowicz J; Rojo MG
    Folia Histochem Cytobiol; 2010 Jan; 48(1):19-25. PubMed ID: 20529811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A comparative study of hormone receptors in breast cancer with quantitative immunocytochemistry and biochemistry].
    Marcot I; Migeon C; Parache RM; Marchal S; Virion JM
    Bull Cancer; 1997 Jun; 84(6):613-8. PubMed ID: 9295864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical determination of estrogen and progesterone receptor status in breast cancer.
    Tesch M; Shawwa A; Henderson R
    Am J Clin Pathol; 1993 Jan; 99(1):8-12. PubMed ID: 7678483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.